SCHEMBL25520567

SCHEMBL25520567

CSc1ncc(C#N)c(NC2CCOCC2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 4/20 0.53
NSD2 O96028 1/20 0.41
MERTK Q12866 1/20 0.41
MAPK1 P28482 3/20 0.40
IRAK4 Q9NWZ3 3/20 0.39
PDE4B Q07343 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TTK P33981 1/20 0.37
PRKCQ Q04759 1/20 0.36
PRKCD Q05655 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 1/20 0.36
GABBR2 O75899 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1227148 0.88 MEN1 (0.47) LRRK2MERTKPDE4BKDM4EPRKCQ
SCHEMBL1226660 0.88 LRRK2 (0.44) LRRK2MERTKPDE4BKDM4EPRKCQ
SCHEMBL25219740 0.81 LRRK2 (0.41) LRRK2MERTKIRAK4KDM4EPRKCQ
SCHEMBL16822154 0.81 MERTK (0.41) LRRK2MERTKIRAK4KDM4EPRKCQ
SCHEMBL16822121 0.81 MERTK (0.41) LRRK2MERTKIRAK4KDM4EPRKCQ
SCHEMBL1227640 0.80 MERTK (0.49) LRRK2MERTKKDM4EPRKCQPRKCD
SCHEMBL1227635 0.80 MERTK (0.49) LRRK2MERTKKDM4EPRKCQPRKCD
SCHEMBL13625177 0.80 MERTK (0.49) LRRK2MERTKKDM4EPRKCQPRKCD
SCHEMBL1227632 0.80 MERTK (0.49) LRRK2MERTKKDM4EPRKCQPRKCD
SCHEMBL25276365 0.79 NSD2 (0.40) LRRK2NSD2MERTKMAPK1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed